“The COVID-19 pandemic brought two stark realities into clear view: first, clinical labs are a critical component for patient health and treatment, and, second, there are significant gaps in the access to lifesaving tests. A new technology-enabled clinical partnership is aiming to close these gaps by leveraging the assets of university and independent labs to underserved markets.”
Read the rest of the article on the Clinical Lab Products website at clpmag.com.